NATR (NATR) revenue breakdown

· Market cap $222M

By segment, Asia is the largest at 46% of fiscal 2025 revenue; Europe grew fastest, 13% a year over 9 years.

By product, General health is the largest at 40% of fiscal 2025 revenue; Immune grew fastest, 12% a year over 2 years.

Revenue by segment

Fiscal years, as NATR reports them in its 10-K filings; fiscal 2025 total $480M.

Segments2016201720182019202020212022202320242025Share
Asia——$139M$139M$139M$177M$186M$201M$208M$222M 46%
North America$125M$124M$144M$138M$145M$150M$133M$140M$139M$144M 30%
Europe$30M$32M$56M$63M$78M$92M$79M$81M$85M$93M 19%
Latin America and Other——$25M$23M$23M$26M$23M$23M$23M$22M 5%
NSP Americas$176M$166M———————— —
NSP China$10M$20M———————— —

Revenue by product

Fiscal years, as NATR reports them in its 10-K filings; fiscal 2025 total $480M.

Products202320242025Share
General health$174M$184M$192M 40%
Digestive$104M$112M$124M 26%
Cardiovascular$84M$82M$82M 17%
Immune$32M$39M$41M 9%
Personal care$18M$18M$23M 5%
Weight management$33M$21M$18M 4%

Revenue by region

Fiscal years, as NATR reports them in its 10-K filings; fiscal 2025 total $480M.

Regions2016201720182019202020212022202320242025Share
Other$135M$149M$159M$164M$188M$222M$196M$204M$161M$173M 36%
United States$148M$141M$134M$128M$135M$138M$123M$129M$128M$133M 28%
Taiwan—————$23M$48M$62M$71M$67M 14%
Japan————————$44M$56M 12%
Korea$58M$52M$72M$71M$62M$61M$55M$50M$51M$51M 11%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for NATR.
Open NATR in Investingly

Questions

Where does NATR make its money?

In fiscal 2025, by segment: Asia $222M, North America $144M, Europe $93M, Latin America and Other $22M.

From NATR's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.